Recent Blog Articles

Staying Healthy

What’s new with the shingles vaccine

Updated: February 01, 2018

Shingrix offers more protection than its predecessor.

 Image: © Zerbor/Thinkstock

A new vaccine to protect against shingles could offer almost double the protection for older adults compared with the one currently in use.

The original shingles vaccine, Zostavax, which was issued in 2006, reduces the risk of shingles by an average of 51%, but it becomes less effective as people age. It has a success rate of 70% for people ages 55 to 59, but that drops to 64% for those in their 60s, 41% for those in their 70s, and only 18% for those ages 80 and older.

To continue reading this article, you must log in.

Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.

  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »

I'd like to receive access to Harvard Health Online for only $4.99 a month.

Sign Me Up

Already a member? Login ».


As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.